Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| YK-CAF-TAU-2025 | Other Identifier | Internal protocol identifier assigned by Burdur Mehmet Akif Ersoy University |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Burdur Mehmet Akif Ersoy University | OTHER |
Not provided
Not provided
Not provided
Not provided
This study aims to investigate the effects of low-dose caffeine and taurine, administered separately and in combination, on anaerobic, neuromuscular, and cognitive performance. The study is designed as a randomized, double-blind, placebo-controlled crossover trial involving trained man participants. Each participant will complete experimental sessions under different supplementation conditions, including caffeine, taurine, their combination, and placebo. Performance outcomes will include anaerobic power, neuromuscular performance, and cognitive function assessments. The findings will help clarify whether the combined ingestion of caffeine and taurine produces synergistic performance effects compared with isolated supplementation.
Caffeine and taurine are commonly consumed ingredients in coffee and energy drinks and are frequently used as ergogenic aids to enhance physical and cognitive performance. Although both compounds have been widely investigated individually, evidence regarding their combined effects remains limited and inconsistent. Understanding whether caffeine and taurine produce synergistic or additive effects is important for clarifying their role in sports performance and supplementation strategies.
The present study is designed as a randomized, double-blind, placebo-controlled crossover trial to examine the isolated and combined effects of low-dose caffeine and taurine on anaerobic, neuromuscular, and cognitive performance in trained individuals. Participants will complete multiple experimental sessions under different supplementation conditions, including caffeine, taurine, their combination, and placebo. During each session, participants will undergo standardized performance assessments to evaluate anaerobic power, neuromuscular performance, and cognitive function. The crossover design allows each participant to serve as their own control, minimizing inter-individual variability. The findings of this study may provide further insight into the potential synergistic effects of caffeine and taurine supplementation on performance outcomes.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Caffeine | Experimental | Participants receive caffeine at a dose of 2 mg/kg body mass in capsule form 60 minutes prior to the performance testing session. Anaerobic, neuromuscular, and cognitive performance outcomes are assessed following supplementation. |
|
| Taurine | Experimental | Participants receive taurine at a dose of 10 mg/kg body mass in capsule form 60 minutes prior to the performance testing session. Anaerobic, neuromuscular, and cognitive performance outcomes are assessed following supplementation. |
|
| Caffeine + Taurine | Experimental | Participants receive a combination of caffeine (2 mg/kg) and taurine (10 mg/kg) in capsule form 60 minutes prior to the performance testing session. Performance assessments include anaerobic, neuromuscular, and cognitive outcomes. |
|
| Plasebo (Maltodextrine 300 mg) | Placebo Comparator | Participants receive a placebo capsule containing maltodextrin (300 mg) 60 minutes prior to the performance testing session. The same performance tests are administered to allow comparison with the supplementation conditions. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Caffeine | Dietary Supplement | Caffeine administered at a dose of 2 mg/kg body mass in capsule form, 60 minutes prior to performance testing. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Anaerobic Power | Anaerobic power measured during the Wingate Anaerobic Test following supplementation conditions (caffeine, taurine, caffeine + taurine, and placebo). | 60 minutes after supplementation |
| Measure | Description | Time Frame |
|---|---|---|
| Neuromuscular Performance | Neuromuscular performance assessed using handgrip strength measured with a hand dynamometer following supplementation. | 60 minutes after supplementation |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Only male participants are eligible to participate in this study.
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Yakup Köse, MsC | Burdur Mehmet Akif Ersoy University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Burdur Mehmet Akif Ersoy University Faculty of Sport Science | Burdur | Merkez | 15100 | Turkey (Türkiye) |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| Result | Köse Y, Ulaş M, Atay E. Synergistic Effects of Low-Dose Caffeine and Taurine on Anaerobic, Neuromuscular, and Cognitive Performance: A Double-Blind Randomized Placebo-Controlled Crossover Study. 2026. | ||
| 42421135 | Derived | Kose Y, Ulas M, Atay E. Effects of combined low-dose caffeine and taurine on anaerobic, neuromuscular, and cognitive performance: a double-blind randomized placebo-controlled crossover study. BMC Sports Sci Med Rehabil. 2026 Jul 8. doi: 10.1186/s13102-026-01863-x. Online ahead of print. |
| Label | URL |
|---|---|
| Open Scince Framework | View source |
| ID | Type | URL | Comment |
|---|---|---|---|
| Informed Consent Form | Informed Consent Form | View IPD |
Individual participant-level data will not be publicly shared. Aggregated data supporting the findings of this study may be available from the corresponding author upon reasonable request.
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_ICF | Yes | No | Yes | Study Protocol and Informed Consent Form | Mar 6, 2026 | Mar 10, 2026 | Prot_ICF_000.pdf |
Not provided
| ID | Term |
|---|---|
| D002110 | Caffeine |
| D013654 | Taurine |
| ID | Term |
|---|---|
| D014970 | Xanthines |
| D000470 | Alkaloids |
| D006571 | Heterocyclic Compounds |
| D011688 | Purinones |
Not provided
Not provided
Participants complete multiple experimental sessions under different supplementation conditions (caffeine, taurine, caffeine + taurine, and placebo) in a randomized crossover design. Each participant receives all interventions in separate sessions with appropriate washout periods.
Not provided
Not provided
Not provided
| taurine | Dietary Supplement | Taurine administered at a dose of 10 mg/kg body mass in capsule form, 60 minutes prior to performance testing. |
|
|
| Caffeine + Taurine | Dietary Supplement | Combined supplementation of caffeine (2 mg/kg) and taurine (10 mg/kg) administered 60 minutes prior to testing. |
|
|
| Placebo | Dietary Supplement | Placebo capsule containing maltodextrin (300 mg) administered 60 minutes prior to testing. |
|
|
| D011687 |
| Purines |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D017738 | Alkanesulfonic Acids |
| D000473 | Alkanes |
| D006839 | Hydrocarbons, Acyclic |
| D006838 | Hydrocarbons |
| D009930 | Organic Chemicals |
| D013451 | Sulfonic Acids |
| D013456 | Sulfur Acids |
| D013457 | Sulfur Compounds |